Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/16731

TDMS Study 05135-06 Pathology Tables

NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50




       Facility:  Battelle Northwest

       Chemical CAS #:  78-79-5

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All




































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04    
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          CONTROL      70 PPM       220 PPM      700 PPM      2200 PPM     7000 PPM        
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          40           40           40           40           40           40           
                                                                                                                                    
  Scheduled Sacrifice                                 10           10           10           10           10           10           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 1            1            1            1            1            5           
    Natural Death                                      1            1            1            2            3            4           
    Accidently Killed                                  1                                                                            
  Survivors                                                                                                                         
    Terminal Sacrifice                                27           28           28           27           26           21           
                                                                                                                                    
  Animals Examined Microscopically                    40           40           40           40           40           40           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (39)         (10)         (10)         (12)         (37)         (33)         
      Inflammation, Suppurative                                                               1 (8%)       1 (3%)                   
   Intestine Large, Cecum                             (40)         (12)         (11)         (14)         (37)         (37)         
      Parasite                                                                                1 (7%)                                
   Intestine Small, Duodenum                          (39)         (12)         (10)         (12)         (37)         (36)         
      Serosa, Inflammation, Chronic                                                                        1 (3%)                   
   Intestine Small, Jejunum                           (40)         (11)         (11)         (13)         (38)         (36)         
      Parasite                                                                                                          1 (3%)      
   Intestine Small, Ileum                             (40)         (11)         (11)         (13)         (37)         (36)         
      Parasite                                                                                                          1 (3%)      
   Liver                                              (40)         (40)         (39)         (40)         (40)         (38)         
      Angiectasis                                                                             2 (5%)       1 (3%)       2 (5%)      
      Basophilic Focus                                 3 (8%)       1 (3%)       2 (5%)       4 (10%)      5 (13%)      4 (11%)     
      Clear Cell Focus                                                                        2 (5%)                    1 (3%)      
      Deformity                                        1 (3%)                                                                       
      Eosinophilic Focus                               1 (3%)                                 6 (15%)      5 (13%)      3 (8%)      
      Hematopoietic Cell Proliferation                                                                     2 (5%)       1 (3%)      
      Hyperplasia, Focal                                                                                   1 (3%)                   
      Infarct                                                       1 (3%)                                                          
      Inflammation, Chronic                                                                                1 (3%)                   
      Mixed Cell Focus                                                           1 (3%)       1 (3%)       2 (5%)       3 (8%)      
      Necrosis                                                                   1 (3%)       1 (3%)                    2 (5%)      
      Vacuolization Cytoplasmic                       22 (55%)     25 (63%)     27 (69%)     20 (50%)     24 (60%)     14 (37%)     
      Bile Duct, Hyperplasia                                                                                            1 (3%)      
   Mesentery                                          (1)          (2)                       (2)          (4)          (2)          
      Angiectasis                                                                             1 (50%)                               
      Necrosis                                         1 (100%)     2 (100%)                  2 (100%)     2 (50%)      2 (100%)    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04    
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          CONTROL      70 PPM       220 PPM      700 PPM      2200 PPM     7000 PPM        
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Pancreas                                           (40)         (40)         (39)         (40)         (40)         (38)         
      Angiectasis                                                                                                       1 (3%)      
      Focal Cellular Change                            2 (5%)       1 (3%)                    5 (13%)      3 (8%)       6 (16%)     
      Inflammation, Chronic                                         2 (5%)                                 1 (3%)       1 (3%)      
      Duct, Cyst                                                    1 (3%)                                              1 (3%)      
   Salivary Glands                                    (40)         (12)         (11)         (13)         (40)         (38)         
      Inflammation, Suppurative                        2 (5%)                                                                       
   Stomach, Forestomach                               (40)         (40)         (39)         (40)         (40)         (38)         
      Angiectasis                                                                                          2 (5%)                   
      Infiltration Cellular, Mast Cell                                           1 (3%)                                             
      Epithelium, Hyperplasia                          1 (3%)       2 (5%)                   16 (40%)     19 (48%)     15 (39%)     
   Stomach, Glandular                                 (40)         (40)         (39)         (40)         (38)         (37)         
      Hyperplasia                                                   1 (3%)                    3 (8%)       2 (5%)       4 (11%)     
      Inflammation, Suppurative                                     1 (3%)                    1 (3%)                    2 (5%)      
      Necrosis                                                                                                          2 (5%)      
      Pigmentation, Hemosiderin                                     1 (3%)                    1 (3%)                                
      Ulcer                                            1 (3%)                                 1 (3%)                                
   Tooth                                              (1)                       (2)                                                 
      Deformity                                                                  1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (40)         (12)         (11)         (13)         (40)         (38)         
      Pericardium, Hemorrhage                          1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (40)         (12)         (11)         (13)         (39)         (38)         
      Hematopoietic Cell Proliferation                                                                     1 (3%)                   
      Hemorrhage                                       1 (3%)                                                                       
      Hyperplasia                                      6 (15%)                                             8 (21%)      6 (16%)     
      Hyperplasia, Focal                                                                                                1 (3%)      
      Hypertrophy, Focal                               5 (13%)                                             6 (15%)      4 (11%)     
   Islets, Pancreatic                                 (40)         (40)         (39)         (40)         (40)         (38)         
      Angiectasis                                                                                                       1 (3%)      
      Hyperplasia                                      9 (23%)      9 (23%)     12 (31%)     12 (30%)     16 (40%)     13 (34%)     
   Pituitary Gland                                    (38)         (12)         (10)         (13)         (37)         (35)         
      Pars Distalis, Cyst                              2 (5%)                    1 (10%)                                            
      Pars Intermedia, Hyperplasia                     1 (3%)                                                                       
   Thyroid Gland                                      (40)         (12)         (11)         (13)         (39)         (38)         
      Cyst                                             1 (3%)                                              1 (3%)       1 (3%)      
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04    
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          CONTROL      70 PPM       220 PPM      700 PPM      2200 PPM     7000 PPM        
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Follicular Cell, Hyperplasia                                                                         1 (3%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (40)         (12)         (11)         (13)         (40)         (39)         
      Hyperplasia                                                                                                       1 (3%)      
      Inflammation                                                  1 (8%)                                              1 (3%)      
   Preputial Gland                                    (40)         (13)         (11)         (16)         (39)         (37)         
      Angiectasis                                                                             1 (6%)                    1 (3%)      
      Atrophy                                                                                              1 (3%)       1 (3%)      
      Hemorrhage                                                    1 (8%)                                                          
      Inflammation, Chronic                                                                   1 (6%)                    1 (3%)      
      Inflammation, Suppurative                        1 (3%)       3 (23%)                                1 (3%)                   
      Necrosis                                                      1 (8%)                                                          
   Prostate                                           (38)         (12)         (11)         (13)         (39)         (37)         
      Hyperplasia                                                                                          2 (5%)                   
      Inflammation, Suppurative                                                               2 (15%)                               
   Seminal Vesicle                                    (40)         (12)         (11)         (13)         (40)         (38)         
      Inflammation, Suppurative                                                               1 (8%)                                
   Testes                                             (40)         (40)         (39)         (40)         (40)         (39)         
      Atrophy                                                                    1 (3%)                                 8 (21%)     
      Mineralization                                                                                                    1 (3%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (40)         (12)         (11)         (13)         (40)         (38)         
      Angiectasis                                                                                          1 (3%)                   
      Hyperplasia                                      1 (3%)                                 1 (8%)       2 (5%)       4 (11%)     
   Lymph Node                                         (1)          (1)                                                              
      Iliac, Hyperplasia                               1 (100%)     1 (100%)                                                        
      Inguinal, Hyperplasia                            1 (100%)                                                                     
   Lymph Node, Mesenteric                             (40)         (13)         (9)          (13)         (39)         (37)         
      Hyperplasia                                                   1 (8%)                    1 (8%)       1 (3%)                   
      Necrosis                                                      1 (8%)                                                          
   Lymph Node, Mediastinal                            (19)         (10)         (7)          (9)          (20)         (22)         
      Hyperplasia                                                                                          1 (5%)                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04    
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          CONTROL      70 PPM       220 PPM      700 PPM      2200 PPM     7000 PPM        
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Spleen                                             (40)         (15)         (11)         (13)         (40)         (38)         
      Accessory Spleen                                              1 (7%)                                                          
      Hematopoietic Cell Proliferation                 2 (5%)       1 (7%)                                 2 (5%)       4 (11%)     
      Infiltration Cellular, Histiocyte                                                       1 (8%)                                
      Necrosis                                                      1 (7%)                                                          
      Pigmentation, Melanin                            1 (3%)       3 (20%)                   1 (8%)       1 (3%)                   
   Thymus                                             (40)         (12)         (11)         (13)         (39)         (36)         
      Atrophy                                                                                 1 (8%)       1 (3%)                   
      Necrosis                                                      2 (17%)                                             1 (3%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (40)         (14)         (11)         (14)         (40)         (39)         
      Cyst Epithelial Inclusion                                                                            1 (3%)                   
      Hemorrhage                                                    1 (7%)                                 1 (3%)                   
      Inflammation, Suppurative                                     2 (14%)                                             1 (3%)      
      Prepuce, Inflammation, Chronic                   2 (5%)       1 (7%)                    1 (7%)       2 (5%)       2 (5%)      
      Sebaceous Gland, Hyperplasia                                                                                      1 (3%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (40)         (12)         (12)         (13)         (40)         (39)         
      Osteopetrosis                                                              1 (8%)                                             
   Skeletal Muscle                                    (40)         (40)         (39)         (40)         (40)         (38)         
      Atrophy                                                                                                           4 (11%)     
      Inflammation                                                               1 (3%)                    1 (3%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (40)         (12)         (11)         (13)         (40)         (38)         
      Cyst Epithelial Inclusion                                                  1 (9%)                                             
      Hemorrhage                                                                              2 (15%)                               
      Mineralization                                   1 (3%)                                              2 (5%)                   
      Necrosis                                                                                1 (8%)                                
   Peripheral Nerve                                   (40)         (40)         (39)         (39)         (38)         (38)         
      Sciatic, Degeneration                                                                   1 (3%)       1 (3%)       5 (13%)     
   Spinal Cord                                        (40)         (40)         (39)         (40)         (39)         (38)         
      Degeneration                                     4 (10%)     20 (50%)     19 (49%)     28 (70%)     18 (46%)     23 (61%)     
      Meninges, Cyst Epithelial Inclusion                                        1 (3%)                                 1 (3%)      
      Meninges, Hemorrhage                             1 (3%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04    
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          CONTROL      70 PPM       220 PPM      700 PPM      2200 PPM     7000 PPM        
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (40)         (12)         (11)         (13)         (38)         (38)         
      Inflammation                                                                                                      1 (3%)      
   Lung                                               (40)         (40)         (39)         (40)         (40)         (38)         
      Congestion                                       3 (8%)                                                           2 (5%)      
      Hemorrhage                                       3 (8%)       2 (5%)       2 (5%)       1 (3%)       2 (5%)       2 (5%)      
      Metaplasia, Osseous                              1 (3%)                                                                       
      Thrombosis                                                                              1 (3%)                    1 (3%)      
      Alveolar Epithelium, Hyperplasia                 1 (3%)       1 (3%)                    3 (8%)       5 (13%)      7 (18%)     
   Nose                                               (40)         (40)         (39)         (40)         (40)         (38)         
      Inflammation                                                                                                      2 (5%)      
      Turbinate, Inflammation                                                    1 (3%)       1 (3%)                                
      Turbinate, Inflammation, Suppurative                                                                              1 (3%)      
      Turbinate, Olfactory Epithelium, Degeneration    1 (3%)       2 (5%)       5 (13%)     12 (30%)     26 (65%)     38 (100%)    
      Turbinate, Olfactory Epithelium,                                                                                              
        Inflammation, Chronic                                                                              1 (3%)      30 (79%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (40)         (12)         (12)         (13)         (40)         (40)         
      Inflammation, Chronic                                                                                             1 (3%)      
   Harderian Gland                                    (40)         (40)         (39)         (40)         (40)         (38)         
      Hyperplasia                                      1 (3%)                    3 (8%)       2 (5%)       3 (8%)       2 (5%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (40)         (13)         (11)         (14)         (40)         (38)         
      Bilateral, Fibrosis                              2 (5%)                                                           1 (3%)      
      Bilateral, Fibrosis, Focal                                                                                        1 (3%)      
      Bilateral, Hydronephrosis                        2 (5%)       1 (8%)                    1 (7%)       1 (3%)       1 (3%)      
      Bilateral, Metaplasia, Osseous                   1 (3%)                                              1 (3%)                   
      Bilateral, Nephropathy                                                                                            1 (3%)      
      Bilateral, Cortex, Pelvis, Inflammation,                                                                                      
         Suppurative                                                                          1 (7%)                                
      Bilateral, Pelvis, Inflammation, Suppurative     1 (3%)       1 (8%)                    1 (7%)                                
      Bilateral, Renal Tubule, Hyperplasia             1 (3%)                                              2 (5%)                   
   Urinary Bladder                                    (40)         (15)         (11)         (13)         (40)         (38)         
      Calculus Micro Observation Only                  1 (3%)       1 (7%)                                                          
      Dilatation                                       1 (3%)       2 (13%)                   1 (8%)                                
      Inflammation, Suppurative                        2 (5%)                                                           1 (3%)      
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 05135-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SIX MONTH EXPOS.                                     ISOPRENE                                         Date: 10/15/04    
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:27:50    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          CONTROL      70 PPM       220 PPM      700 PPM      2200 PPM     7000 PPM        
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Hyperplasia             1 (3%)                                 1 (8%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------